載入...
Randomized Trial Comparing Esomeprazole and Rabeprazole in First-line Eradication Therapy for Helicobacter pylori Infection based on the Serum Levels of Pepsinogens
OBJECTIVE: CYP2C19 metabolic activity influences the efficacy of Helicobacter pylori eradication therapies comprising PPIs. Rabeprazole (RPZ) and esomeprazole (EPZ) are PPIs not extensively metabolized by CYP2C19. The aim of this study was to elucidate whether or not first-line triple therapies usin...
Na minha lista:
| 發表在: | Intern Med |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
The Japanese Society of Internal Medicine
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5519461/ https://ncbi.nlm.nih.gov/pubmed/28674348 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.56.7823 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|